Key result
A 12-gene profile distinguished heart failure patients from healthy controls better than hydroxyproline content and shared features with activated cardiac fibroblasts in murine models.
Why the study?
It is unclear whether different types of heart disease correlate with different subtypes of activated fibroblasts and how well such diversity is modeled during in vitro activation of primary cardiac fibroblasts.
Observational (n=65)
A 12-gene expression profile identifies cardiac fibroblast activation shared across human heart failure, murine disease models, and in vitro cell cultures.
Hypothesis-generating for fibroblast-targeted HF therapies; extends cross-species activation signatures but requires human validation before clinical consideration.
Many heart diseases are associated with fibrosis, but it is unclear whether different types of heart disease correlate with different subtypes of activated fibroblasts and to which extent such diversity is modeled during in vitro activation of primary cardiac fibroblasts. Analyzing the expression of 82 fibrosis related genes in 65 heart failure (HF) patients, we identified a panel of 12 genes clearly distinguishing HF patients better from healthy controls than measurement of the collagen-related hydroxyproline content. A subcluster enriched in ischemic HF was recognized, but not for diabetes, high BMI, or gender. Single-cell transcriptomic analysis of in vitro activated mouse cardiac fibroblasts distinguished 6 subpopulations, including a contractile Acta2high precursor population, which was predicted by time trajectory analysis to develop into Acta2low subpopulations with high production of extracellular matrix molecules. The 12 gene profile identified in HF patients showed highest similarity to the fibroblast subset with the strongest expression of extracellular matrix molecules. Population markers identified were furthermore able to clearly cluster different disease stages in a murine model for myocardial infarct. These data suggest that major features of cardiac fibroblast activation in heart failure patients, in murine heart disease models, and in cell culture of primary murine cardiac fibroblast are shared.
No takes yet. Share an insight, caveat, or question.
Herum et al. (2022) conducted an observational in Heart failure (n=65). Heart failure vs. Healthy controls was evaluated on Identification of a gene panel distinguishing HF patients from healthy controls. A 12-gene profile distinguished heart failure patients from healthy controls better than hydroxyproline content and shared features with activated cardiac fibroblasts in murine models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: